Not a good buy right now for an impatient investor: price (~24.5 pre-market) is already sitting at/above key resistance (R1 ~24.45) while Street price targets cluster at/under the current price.
Near-term upside looks limited versus downside risk into earnings (2026-02-11 pre-market) given weak fundamentals and recent analyst downgrades.
Options flow is bullish (call-heavy), but that appears more like positioning/speculation into earnings than confirmation of a sustained uptrend.
Trend/price location: Pre-market ~24.51 (+0.12%) with the market weak (S&P 500 pre-market -0.58%). KHC is pressing into resistance.
Momentum: MACD histogram +0.137 and expanding → short-term momentum improving.
RSI(6): ~69.6 → near overbought/upper-neutral; risk of a pullback if it fails to break and hold above resistance.
Moving averages: Converging → consolidation/indecision; not a clean trending setup.
Key levels: Pivot 23.50 (important near-term support). Resistance R1 24.45 (being tested), then R2 25.03. A rejection near 24.45–25.03 increases odds of mean reversion back toward ~23.5.
Pattern-based forward odds (provided): ~70% chance of -0.45% next day, +1.98% next week, -1.51% next month → choppy with a slightly negative monthly bias.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: Put/Call OI 0.73 and very low put/call volume 0.21 → traders are positioned more bullish (calls dominating).
Volatility: 30D IV ~28.85 with IV percentile ~71 → options are relatively expensive vs its own history (elevated event premium into earnings).
Activity: Today’s volume ~35.2k, ~94% of 30D average → active but not a blowout; suggests “steady” bullish skew rather than panic hedging.
Takeaway: Options market leans bullish, but elevated IV into earnings often implies two-way risk; for an impatient entry, you’re paying up for uncertainty.
Technical Summary
Sell
6
Buy
8
Positive Catalysts
show stabilization in volumes/margins or better-than-feared guidance, the stock could squeeze modestly toward ~25.
Neutral/Negative Catalysts
Earnings catalyst risk on 2026-02-11 (pre-market): downside if volumes remain pressured or guidance disappoints.
Analyst tone is deteriorating (downgrades + lower price targets), signaling limited confidence in near-term recovery.
Bottom line: Fundamentals (growth and margins) are moving the wrong direction heading into the next earnings print.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: clear negative drift—multiple price target cuts and downgrades in January 2026.
JPMorgan (2026-01-21): Neutral; PT cut to $24; expects volume pressures to persist in 2026.
BNP Paribas (2026-01-21): Downgrade to Underperform; PT $22.
Jefferies (2026-01-20): Hold; PT cut to $23; cautious on demand, consumer backdrop, and investment needs.
Morgan Stanley (2026-01-16): Downgrade to Underweight; PT cut to $24; highlights competitive/private label risk.
Wall Street pros vs cons:
Pros: dividend appeal; any cost relief/tariff dynamics could help optics.
Cons: persistent volume declines, tougher competition/private label, and continued investment needs limiting margin recovery.
Practical read-through: with targets mostly ~$22–$24 and the stock ~24.5 pre-market, Street sees little upside from here in the near term.
Wall Street analysts forecast KHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KHC is 25.86 USD with a low forecast of 24 USD and a high forecast of 28 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
Wall Street analysts forecast KHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KHC is 25.86 USD with a low forecast of 24 USD and a high forecast of 28 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
14 Hold
1 Sell
Hold
Current: 24.445
Low
24
Averages
25.86
High
28
Current: 24.445
Low
24
Averages
25.86
High
28
JPMorgan
Neutral
downgrade
$25 -> $24
AI Analysis
2026-01-21
Reason
JPMorgan
Price Target
$25 -> $24
AI Analysis
2026-01-21
downgrade
Neutral
Reason
JPMorgan lowered the firm's price target on Kraft Heinz to $24 from $25 and keeps a Neutral rating on the shares ahead of the Q4 report on February 11. The firm sees the company's volume pressures persisting in 2026. Kraft faces ongoing volume declines and likely stepped up investments this year, the analyst tells investors in a research note.
BNP Paribas
Neutral -> Underperform
downgrade
$22
2026-01-21
Reason
BNP Paribas
Price Target
$22
2026-01-21
downgrade
Neutral -> Underperform
Reason
BNP Paribas downgraded Kraft Heinz to Underperform from Neutral with a $22 price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for KHC
